Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04471935 · ClinicalTrials.gov registry record · NA
Speech Hero Home Therapy for Aphasia
A NA study of Broca Aphasia, sponsored by Flint Rehabilitation Devices.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04471935 is a NA study of Broca Aphasia that has completed, run by Flint Rehabilitation Devices. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04471935, a NA study of Broca Aphasia, has completed, sponsored by Flint Rehabilitation Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will run an at-home usability study of a newly developed speech therapy app called Speech Hero with 10 individuals with Broca's aphasia in the chronic stage of stroke. The Speech Hero app allows users to perform rhythm-based speech exercises at home. For this study participants will be instructed to use Speech Hero for at least 10 hours over a 4-week period.
Conditions Studied
Interventions
- DEVICE At home Speech Hero therapy app
Study Locations (1)
Texas
- Callier Center at University of Texas Dallas - Richardson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-07-20 |
| Est. Completion | 2021-10-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04471935
The ClinicalTrials.gov registry entry for NCT04471935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Flint Rehabilitation Devices, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Broca Aphasia appearing as the primary indexed condition, and to 1 intervention - of which At home Speech Hero therapy app is the first listed.
NCT04471935 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04471935 about?
NCT04471935 is a clinical study titled "Speech Hero Home Therapy for Aphasia". The investigators will run an at-home usability study of a newly developed speech therapy app called Speech Hero with 10 individuals with Broca's aphasia in the chronic stage of stroke. The Speech Hero app allows users to perform rhythm-based speech exercises at home. For this study participants wil...
What is the current status of trial NCT04471935?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-07-20. Estimated completion is 2021-10-20.
What conditions does trial NCT04471935 study?
This clinical trial studies the following conditions: Broca Aphasia.
What interventions are being tested in trial NCT04471935?
The interventions under investigation include: At home Speech Hero therapy app (DEVICE).
Who is sponsoring clinical trial NCT04471935?
This trial is sponsored by Flint Rehabilitation Devices, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04471935 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.